1. Inicio
  2. Investigación
  3. Grupos de investigación
  4. Enfermedades Infecciosas

Enfermedades Infecciosas

Buscador de publicaciones

Sólo se han incluido artículos originales, editoriales y revisiones.

  • Barbero Allende JM, Gómez-Junyent J, Sorlí Redó L, Rodríguez-Pardo D, Murillo Rubio Ó, Fernández Sampedro M, Escudero-Sánchez R, García Gutiérrez M, Portillo ME, Sancho I, Rico Nieto A, Guio Carrión L, Soriano A, Morata Ruiz L.

    Description of reinfection of joint prosthesis after 2-stage replacement (infection of the 2nd stage prosthesis): A multicenter study.

    Enfermedades Infecciosas Y Microbiologia Clinica (english Ed.) . : .

    [doi:10.1016/j.eimce.2023.07.002]

  • Serrano-Villar S, Tincati C, Raju SC, Sáenz JS, Moreno E, Bargiela R, Cabello-Ubeda A, Sendagorta E, Kurz A, Perez Molina JA, de Benito A, Hov JR, Fernandez-Lopez L, Muriel A, Del Campo R, Moreno S, Trøseid M, Seifert J, Ferrer M.

    Microbiome-derived cobalamin and succinyl-CoA as biomarkers for improved screening of anal cancer.

    NATURE MEDICINE . 29(7): 1738-1749. Nº de citas: 2

    [doi:10.1038/s41591-023-02407-3]

  • Rosas Cancio-Suárez M, Díaz-Álvarez J, Ron R, Martínez-Sanz J, Serrano-Villar S, Moreno S, Sánchez-Conde M.

    From Innovation to Implementation: The Evolution of HIV Pre-Exposure Prophylaxis and Future Implications.

    PATHOGENS . 12(7): .

    [doi:10.3390/pathogens12070924]

  • Sojo-Dorado J, López-Hernández I, Hernández-Torres A, Retamar-Gentil P, Merino de Lucas E, Escolà-Vergé L, Bereciartua E, García-Vázquez E, Pintado V, Boix-Palop L, Natera-Kindelán C, Sorlí L, Borrell N, Amador-Prous C, Shaw E, Jover-Saenz A, Molina J, Martínez-Álvarez RM, Dueñas CJ, Calvo-Montes J, Lecuona M, Pomar V, Borreguero I, Palomo-Jiménez V, Docobo-Pérez F, Pascual Á, Rodríguez-Baño J.

    Effectiveness of fosfomycin trometamol as oral step-down therapy for bacteraemic urinary tract infections due to MDR Escherichia coli: a post hoc analysis of the FOREST randomized trial

    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY . 78(7): 1658-1666.

    [doi:10.1093/jac/dkad147]

  • Ruiz-Cáceres I, Hermida Romero T, Guerra Merino I, Portu Zapirain J, Pérez-Mies B, Sánchez-Conde M, Riaño MA, Rubio R, Fortés Alen J, Vidal González Á, Salas Antón C, Múñez E, Sánchez Sánchez R, Corona-Mata D, Aldecoa Ansorregui I, Miró JM, Beloqui Pérez de Obanos R, Ibero C, Gómez-Román J, Fariñas MC, Tabuyo Bello T, de Alava E, Cisneros JM, Matías-Guiu X, Rivero A.

    Post-mortem findings in Spanish patients with COVID-19; a special focus on superinfections.

    Frontiers In Medicine . 10: 1151843-1151843.

    [doi:10.3389/fmed.2023.1151843]

  • Maia C, Conceição C, Pereira A, Rocha R, Ortuño M, Muñoz C, Jumakanova Z, Pérez-Cutillas P, Özbel Y, Töz S, Baneth G, Monge-Maillo B, Gasimov E, Van der Stede Y, Torres G, Gossner CM, Berriatua E.

    The estimated distribution of autochthonous leishmaniasis by Leishmania infantum in Europe in 2005-2020

    PLOS NEGLECTED TROPICAL DISEASES . 17(7): . Nº de citas: 2

    [doi:10.1371/journal.pntd.0011497]

  • Candel FJ, Barreiro P, Salavert M, Cabello A, Fernández-Ruiz M, Pérez-Segura P, San Román J, Berenguer J, Córdoba R, Delgado R, España PP, Gómez-Centurión IA, González Del Castillo JM, Heili SB, Martínez-Peromingo FJ, Menéndez R, Moreno S, Pablos JL, Pasquau J, Piñana JL, On Behalf Of The Modus Investigators Adenda.

    Expert Consensus: Main Risk Factors for Poor Prognosis in COVID-19 and the Implications for Targeted Measures against SARS-CoV-2

    VIRUSES-BASEL . 15(7): . Nº de citas: 1

    [doi:10.3390/v15071449]

  • González-Sanz M, Berzosa P, Norman FF.

    Updates on Malaria Epidemiology and Prevention Strategies

    CURRENT INFECTIOUS DISEASE REPORTS . 25(7): 131-139. Nº de citas: 1

    [doi:10.1007/s11908-023-00805-9]

  • Puerta-Alcalde P, Monzó-Gallo P, Aguilar-Guisado M, Ramos JC, Laporte-Amargós J, Machado M, Martin-Davila P, Franch-Sarto M, Sánchez-Romero I, Badiola J, Gómez L, Ruiz-Camps I, Yáñez L, Vázquez L, Chumbita M, Marco F, Soriano A, González P, Fernández-Cruz A, Batlle M, Fortún J, Guinea J, Gudiol C, García J, Ruiz Pérez de Pipaón M, Alastruey-Izquierdo A, Garcia-Vidal C.

    Breakthrough invasive fungal infection among patients with haematologic malignancies: A national, prospective, and multicentre study

    JOURNAL OF INFECTION . 87(1): 46-53. Nº de citas: 2

    [doi:10.1016/j.jinf.2023.05.005]

  • Serrano-Villar, Sergio, Ferrer, Manuel.

    How the microbiome can help detect precancerous lesions and prevent anal cancer

    NATURE MEDICINE . 29(7): 1619-1620.

    [doi:10.1038/s41591-023-02421-5]

  • Casado JL, Vizcarra P, Martín-Hondarza A, Gómez-Maldonado S, Muedra-Sánchez M, Del Pino J, Mirabella IG, Martín-Colmenarejo S, Haemmerle J, Fernández-Escribano M, Vallejo A.

    mRNA-based SARS-CoV-2 Comirnaty vaccine elicits weak and short specific memory B cell response in individuals with no previous infection

    Frontiers in immunology . 14: 1127379-1127379.

    [doi:10.3389/fimmu.2023.1127379]

  • García-Ruiz de Morales AG, Martínez-Sanz J, Vivancos-Gallego MJ, Sánchez-Conde M, Vélez-Díaz-Pallarés M, Romero-Hernández B, Vázquez MDG, de Luque CMC, González-Sarria A, Galán JC, Rodríguez FG, Moreno S, Pérez-Elías MJ.

    HIV and HCV screening by non-infectious diseases physicians: can we improve testing and hidden infection rates?

    Frontiers in Public Health . 11: 1136988-1136988.

    [doi:10.3389/fpubh.2023.1136988]

  • Santos JR, Casadellà M, Noguera-Julian M, Micán-Rivera R, Domingo P, Antela A, Portilla J, Sanz J, Montero-Alonso M, Navarro J, Masiá M, Valcarce-Pardeiro N, Ocampo A, Pérez-Martínez L, García-Vallecillos C, Vivancos MJ, Imaz A, Iribarren JA, Hernández-Quero J, Villar-García J, Barrufet P, Paredes R.

    Effectiveness and safety of integrase strand transfer inhibitors in Spain: a prospective real-world study.

    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY . 13: 1187999-1187999.

    [doi:10.3389/fcimb.2023.1187999]

  • González Del Castillo J, Perez Elias MJ, Miguens I, Espinosa B, Juárez R, Piedrafita Lozoya L, Trenc P, Alvarez Manzanares J, Marchena MJ, Rodríguez R, Cabrera N, Grajal P, Navarro C, Piñera P, García F, Moreno S, Miro O.

    Decalogue to promote the implementation and improvement of recommendations for the early diagnosis of HIV in Emergency Departments.

    Enfermedades Infecciosas Y Microbiologia Clinica (english Ed.) . : .

    [doi:10.1016/j.eimce.2023.06.001]

  • Rosas Cancio-Suárez M, Alonso C, Vivancos MJ, Pérez-Elías MJ, Cárdenas MJ, Vélez-Díaz-Pallarés M, Corbacho MD, Martín-Pedraza L, Muriel A, Martínez-Sanz J, Moreno S.

    Impact of COVID-19 on the Care of Patients with HIV Infection.

    Journal Of Clinical Medicine . 12(12): .

    [doi:10.3390/jcm12123882]

  • Moreno-Arrones, OM, Garcia-Hoz, C, del Campo, R, Roy, G, Saceda-Corralo, D, Jimenez-Cauhe, J, Ponce-Alonso, M, Serrano-Villar, S, Jaen, P, Paoli, J, Vano-Galvan, S.

    Folliculitis decalvans has a heterogeneous microbiological signature and impaired immunological response.

    Dermatology . 239(3): 454-461.

    [doi:10.1159/000529301]

  • Quesada Muñoz L, Fernández-Fradejas J, Martinez-Barros H, Sánchez Cuervo M, Martín Rufo M, Pintor Recuenco MDR, Quereda Rodríguez-Navarro C, Álvarez-Díaz AM, Saez de la Fuente J.

    Real-world effectiveness and factors associated with increased mortality in non-critically ill patients with COVID-19 pneumonia receiving remdesivir

    EUROPEAN JOURNAL OF HOSPITAL PHARMACY . : .

    [doi:10.1136/ejhpharm-2023-003729]

  • Aberg JA, Mills A, Moreno S, Slater J, Prakash M, Clark A.

    The evolution of clinical study design in heavily treatment-experienced persons with HIV: A critical review.

    ANTIVIRAL THERAPY . 28(3): .

    [doi:10.1177/13596535231174774]